
Materials · Gold
$108.91
-1.96%
Vol: 5.8M
Friday, May 1, 2026
Newmont reported outstanding Q1 2026 results: adjusted EPS near $2.90 crushed consensus of $2.18-2.22, with revenue of $7.31B vs. expected $6.44-6.57B. Company generated record $3.1B quarterly free cash flow, demonstrating strong operating leverage to higher gold prices. Newmont doubled share repurchase authorization with fresh $6.0B authorization following completion of prior $2.4B program, signaling aggressive capital return strategy. Q1 production of 1.3M attributable gold ounces on track for 2026 guidance of 5.3M ounces. Analyst consensus is Strong Buy with 12-month target of $122.08. Company faces near-term risks from Ghana regulatory changes.
Newmont delivered exceptional Q1 results with record $3.1B quarterly free cash flow and $1.3M attributable gold ounces. Adjusted EPS of $2.90 beat estimate of $2.22 significantly; revenue $7.31B topped $6.44B estimate. Company doubled share repurchase authorization by additional $6B (atop completed $6B program). Vanguard disclosed 7.7% stake in Newmont. Near-term catalysts include record FCF, new $6B buyback, and reaffirmed 2026 production of 5.3Moz. Temporary disruptions at Cadia following magnitude 4.5 earthquake expected to impact Q2 output. Consensus "Strong Buy" with $122.08 PT implies 10.7% upside. 120.5% annual return reflects strong gold price environment.
Newmont delivered strong Q1 2026 results: EPS of $2.90 vs. $2.24 consensus (6th consecutive earnings beat), record $3.1B quarterly free cash flow, and $7.31B revenue. Produced 1.3M attributable gold ounces, 50K tonnes copper, 9M ounces silver. Doubled buyback authorization to additional $6B following completion of prior $2.4B program in latest quarter. Achieved 52.7% EBIT margin and 63.8% EBITDA margin signaling exceptional operating leverage to gold prices. TD Securities raised price target to $129 from $116 on April 27. Stock up 8.41% on bullish sentiment trading near $120.70.
Newmont Corporation faced significant headwinds on April 15, with the stock declining 4.63% after announcing reduced 2026 production guidance of 5.3 million attributable ounces (down 10.2% from 2025) and All-In Sustaining Costs surging to $1,680 per ounce from $1,358 in 2025. The company designated 2026 as a trough year due to operational disruptions at its Cadia mine from seismic activity and declining gold prices. Q1 earnings are expected April 22 with EPS of $2.07. Management disputes with partner Barrick over equipment diversion have escalated to formal litigation in Nevada courts.
Dropped 3.4% April 13 on softer gold. Projected 14% gold output decline with AISC $1,680/oz. Q1 earnings April 23. Barrick JV dispute.
Newmont scheduled Q1 2026 earnings release for April 23 with consensus EPS of $2.02 (+61.6% YoY). Gold rally (+5.9% recent move) supports stock recovery. However, company faces 14% decline in 2026 gold production and rising costs. Strengthened balance sheet with $2.1B net cash. Stock up 19% YTD but down 2.3% past month.
Newmont will release Q1 2026 results after market close April 23. Expanding production capacity with Ahafo North mine in Ghana. Projected 24% Q4 2025 output decrease and 14% full-year decline. Trading at $119.01 with market cap $129.5B. 11 analysts maintain Strong Buy average with $114.18 target.
Newmont rose 1.61% to $118.15 (+2.34% weekly) on gold price strength after crude oil fell $20+/barrel post-ceasefire. Launching Ahafo North mine expansion in Ghana. Q1 earnings April 23 expected $2.02 EPS. AI trading algorithms reinforcing bullish sentiment on precious metal/copper exposure amid fluctuating gold prices.
Newmont will release Q1 2026 results April 23 at 5:30 p.m. EDT. Stock gained 0.228% on April 2, rising from $113.79 to $114.05. Strong recent share gains driven by higher gold prices create near-term catalyst focus. Company balancing production, costs, and capital returns.
Newmont will release Q1 2026 results after market close April 23 with 5:30 p.m. EDT conference call. 2025 delivered strong results with $10.3B operating cash flow, $7.3B record free cash flow, and $7.2B net income. Stock reached all-time high of $134.88 in January 2026 but moderated to ~$95.80 by late March amid "sell-the-news" sentiment following 2026 production guidance flagging temporary trough year. Natascha Viljoen became President/CEO effective January 1, succeeding Tom Palmer. With $4.3B asset sales completed, company positioned for dividend increase or multi-billion buyback in late 2026. Wall Street maintains Strong Buy with $145 median price target.
Newmont jumped 11.7% since Friday April 4 on gold rally as Mideast tensions ease. 5-day winning streak with cumulative gains of 15%; market cap surged ~$16B over 5 days. Launching Ahafo North mine in Ghana. Q1 2026 results April 23.
Newmont experienced a sharp stock recovery driven by a 2.5%+ rise in spot gold prices amid geopolitical developments. Q1 2026 earnings expected at $2.38 per share versus $1.25 in Q1 2025. Newmont is expanding production capacity with Ahafo North mine in Ghana. The stock has fallen 15.7% in under a month. Among 10 analysts, consensus rates Strong Buy with 12-month price target of $114.90.
Newmont Corporation is set to report Q1 2026 earnings on April 23, 2026, with anticipated 65.6% year-over-year EPS growth. The company delivered $2.52 non-GAAP EPS in 2025 and $6.81B revenue with 21% growth driven by gold prices rising 60% YoY. Newmont is expanding production with its Ahafo North mine launch in Ghana. NEM stock has declined 15.7% from February highs. Analyst consensus rates NEM as Strong Buy with 12-month target of $114.90.
Newmont rebounded 1% March 30, down 15.7% from Feb highs. Q1 EPS projected +65.6%. 2025 $1.30B profit with gold up 60%. Ahafo North mine in Ghana launched. Project Catalyst targeting 21% G&A cut. $6B buyback. Consensus Strong Buy $114.9.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| NEMNEWMONT | $108.91 | -1.96% | -1.5% | 9.8x | 0.47 | $118.6B |
| LINLINDE | $508.66 | +1.50% | +0.3% | 25.7x | 0.79 | $232.2B |
| FCXFREEPORT | $56.78 | -1.74% | -5.4% | 15.7x | 1.47 | $82.9B |
| SHWSHERWIN | $317.83 | -1.18% | +1.6% | 24.2x | 1.27 | $79.3B |
| CRHCRH | $115.72 | -2.28% | +11.4% | 18.0x | 1.24 | $79.1B |
| ECLECOLAB | $259.78 | -0.31% | -2.4% | 27.2x | 1.02 | $73.6B |
Price between 50d and 200d. Testing 50d support.